Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

Conditions: Osteomyelitis; Diabetes; Amputation
Interventions: Drug: Rifampin; Drug: Riboflavin Placebo
Sponsors: VA Office of Research and Development
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments